RiskIQ
RiskIQ is a cybersecurity company that specializes in providing threat intelligence and attack surface management solutions. The company was founded in 2009 and is headquartered in San Francisco, California. RiskIQ's platform helps organizations detect and mitigate threats across their digital attack surface, including websites, mobile applications, and social media.
History[edit]
RiskIQ was founded by Elias Manousos, Chris Kiernan, and David Pon. The company has grown significantly since its inception, securing multiple rounds of funding and expanding its product offerings. In 2021, RiskIQ was acquired by Microsoft to enhance its cybersecurity capabilities.
Products and Services[edit]
RiskIQ offers a range of products and services designed to help organizations manage their digital risk. These include:
- RiskIQ Digital Footprint: This service provides visibility into an organization's digital assets, helping to identify and manage risks associated with them.
- RiskIQ PassiveTotal: A threat intelligence platform that aggregates data from various sources to provide insights into potential threats.
- RiskIQ Illuminate: A comprehensive platform that combines digital footprint and threat intelligence capabilities to provide a holistic view of an organization's attack surface.
- RiskIQ External Threats: This service monitors the internet for threats targeting an organization's brand, customers, and employees.
Technology[edit]
RiskIQ's technology leverages a combination of web crawling, data analysis, and machine learning to identify and assess threats. The platform collects data from a variety of sources, including DNS records, SSL certificates, and web content, to build a comprehensive view of an organization's digital presence.
Use Cases[edit]
RiskIQ's solutions are used by organizations across various industries, including finance, healthcare, and retail. Common use cases include:
- Brand Protection: Monitoring for unauthorized use of an organization's brand and taking action to mitigate potential damage.
- Threat Hunting: Identifying and investigating potential threats to an organization's digital assets.
- Incident Response: Providing data and insights to support the investigation and remediation of security incidents.
Acquisition by Microsoft[edit]
In July 2021, Microsoft announced its acquisition of RiskIQ. This acquisition aimed to enhance Microsoft's cybersecurity offerings by integrating RiskIQ's threat intelligence and attack surface management capabilities into its existing security products.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
